Garri explains the Longevity Science Foundation's work as a nonprofit supporting a decentralized and transparent future of longevity research.

At the ninth annual Anti-Aging Research and Drug Discovery event in Copenhagen, Garri Zmudze presented the Longevity Science Foundation to an audience of more than 100 attendees. He emphasised the importance of funding early-stage research to support groundbreaking projects in longevity.
Garri also spoke on two panels exploring topics related to our work at the Longevity Science Foundation. He represented LongeVC, a visionary biotech and longevity venture capital firm, on a panel dedicated to VCs and startups in the longevity space with speakers from VitaDAO, Cambrian Bio, BioAge, Insilico Medicine, Evolution Foundation, Haut AI and Apollo Health. The panellists explored the role of funding for longevity science and why it is vital to encourage developing treatments.
Garri also spoke on a panel exploring the growing role of decentralized science (DeSci) with speakers from VitaDAO Lifespan.IO and Healthspan Capital. DeSci allows more individuals to join the longevity community and have a say in the direction of longevity research.
Watch the panel video here.